Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer

Published:2014-08 Issue:25 Volume:35 Page:7077-7087
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Mittal Anupama,Chitkara Deepak,Behrman Stephan W.,Mahato Ram I.

Funder

Kosten foundation

Fred and Pamela Buffet Cancer Center

Cattlemen's Ball of Nebraska, Inc.

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference58 articles.

1. A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer;Ko;Cancer Chemother Pharmacol,2012

2. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

3. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer;Sultana;J Clin Oncol,2007

4. Folfirinox versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micelle-engineered nanoplatforms for precision oncology;Chemical Engineering Journal;2024-09

2. Gemcitabine–Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice;ACS Applied Materials & Interfaces;2024-05-30

3. Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies;Frontiers in Cell and Developmental Biology;2024-04-25

4. Clinical and Translational Opportunities of Nanocarriers Containing RNAi for the Management of Triple‐Negative Breast Cancer;Advanced Therapeutics;2024-03-25

5. Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review;Cancers;2024-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3